BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
3.190
+0.100 (3.24%)
May 13, 2025, 4:00 PM - Market closed
BioLineRx Employees
BioLineRx had 28 employees as of December 31, 2024. The number of employees decreased by 51 or -64.56% compared to the previous year.
Employees
28
Change (1Y)
-51
Growth (1Y)
-64.56%
Revenue / Employee
$1,033,571
Profits / Employee
-$329,321
Market Cap
11.30M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
BLRX News
- 6 weeks ago - BioLineRx Ltd. (BLRX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - BioLineRx Reports 2024 Financial Results and Provides Corporate Update - PRNewsWire
- 7 weeks ago - BioLineRx to Report 2024 Annual Results on March 31, 2025 - PRNewsWire
- 4 months ago - BioLineRx Issues Letter to Shareholders - PRNewsWire
- 4 months ago - BioLineRx Announces Change to Ratio of American Depositary Shares to Ordinary Shares - PRNewsWire
- 4 months ago - Nasdaq Surges Over 200 Points; BioLineRx Shares Plummet - Benzinga
- 4 months ago - BioLineRx Announces $10 Million Registered Direct Offering - PRNewsWire
- 6 months ago - BioLineRx Ltd. (BLRX) Q3 2024 Earnings Call Transcript - Seeking Alpha